Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,486 | -72,627 | -56,147 | -113,747 | -47,453 |
| Depreciation Amortization | 2,468 | 6,774 | 2,689 | 62,317 | 1,592 |
| Accounts receivable | N/A | N/A | 886 | -437 | -6 |
| Accounts payable and accrued liabilities | -650 | -67 | 333 | -111 | -312 |
| Other Working Capital | 2,891 | -1,621 | -756 | 1,640 | -1,221 |
| Other Operating Activity | 10,607 | 13,577 | 7,574 | 11,972 | 12,062 |
| Operating Cash Flow | $-49,170 | $-53,964 | $-45,421 | $-38,366 | $-35,338 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,826 | 70,253 | -121,188 | 37,738 | -38,577 |
| PPE Investments | -19,247 | -809 | -1,016 | -2,412 | -2,992 |
| Net Acquisitions | N/A | N/A | N/A | 3,449 | N/A |
| Investing Cash Flow | $-68,073 | $69,444 | $-122,204 | $38,775 | $-41,569 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 100 | 0 | 100 | N/A |
| Debt Repayment | -112 | -175 | 0 | N/A | N/A |
| Common Stock Issued | 29,773 | 71,215 | 17,061 | 949 | 139,287 |
| Other Financing Activity | -1,470 | -1,191 | -313 | -493 | -427 |
| Financing Cash Flow | $28,191 | $69,949 | $16,748 | $556 | $138,860 |
| Exchange Rate Effect | N/A | N/A | -774 | -143 | -9 |
| Beginning Cash Position | 155,948 | 70,519 | 222,170 | 221,348 | 159,404 |
| End Cash Position | 66,896 | 155,948 | 70,519 | 222,170 | 221,348 |
| Net Cash Flow | $-89,052 | $85,429 | $-151,651 | $822 | $61,944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,170 | -53,964 | -45,421 | -38,366 | -35,338 |
| Capital Expenditure | -19,247 | -809 | -1,016 | -2,412 | -2,992 |
| Free Cash Flow | -68,417 | -54,773 | -46,437 | -40,778 | -38,330 |